For: | Ma X, Jia YT, Qiu DK. Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: Involvement of nuclear factor kappa B. World J Gastroenterol 2007; 13(31): 4249-4254 [PMID: 17696256 DOI: 10.3748/wjg.v13.i31.4249] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i31/4249.htm |
Number | Citing Articles |
1 |
Maite Duhalde-Vega, Lilia A. Retegui. Uric acid and HMGB1 are involved in the induction of autoantibodies elicited in mice infected with mouse hepatitis virus A59. Autoimmunity 2011; 44(8): 631 doi: 10.3109/08916934.2011.579927
|
2 |
Juan Niu, Dujuan Huang, Rui Zhou, MingXia Yue, Tao Xu, Junna Yang, Li He, Hong Tian, XiaoHong Liu, Junwei Zeng. Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats. Journal of Neuroinflammation 2017; 14(1) doi: 10.1186/s12974-017-0960-0
|
3 |
Jia Liu, Zhi Ma, Han Li, Xiaojiaoyang Li. Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities. Animal Models and Experimental Medicine 2022; 5(2): 95 doi: 10.1002/ame2.12201
|
4 |
Maryam Ebadi, Rahima A. Bhanji, Vera C. Mazurak, Ellina Lytvyak, Andrew Mason, Albert J. Czaja, Aldo J. Montano‐Loza. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2019; 49(2): 173 doi: 10.1111/apt.15029
|
5 |
Dimitrios Bogdanos, Patrick S.C. Leung, M. Eric Gershwin. Mucosal Immunology. 2015; : 1695 doi: 10.1016/B978-0-12-415847-4.00087-2
|
6 |
Na Jin, Qi Wang, Xing Zhang, Donghai Jiang, Hao Cheng, Kejian Zhu. The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus. International Immunopharmacology 2011; 11(9): 1319 doi: 10.1016/j.intimp.2011.04.015
|
7 |
Athanasios Mavropoulos, Timoklia Orfanidou, Christos Liaskos, Daniel S. Smyk, Charalambos Billinis, Miri Blank, Eirini I. Rigopoulou, Dimitrios P. Bogdanos. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: Lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmunity Reviews 2013; 12(5): 580 doi: 10.1016/j.autrev.2012.10.019
|
8 |
Zhi-Wei Zhao, Dietmar-Karl Abendroth, Zheng-Chun Zhou, Yong-Zhi Liu, Fa-Ming Pan, Jian-Jun Ge. Anti-inflammatory and anti-proliferative effects of CBS3830 in arterialized vein grafts in rats. Immunopharmacology and Immunotoxicology 2014; 36(6): 397 doi: 10.3109/08923973.2014.956754
|
9 |
Rong He, Liping Wang, Jiali Zhu, Miaomiao Fei, Suhong Bao, Yan Meng, Yuanyuan Wang, Jinbao Li, Xiaoming Deng. Methane-rich saline protects against concanavalin A-induced autoimmune hepatitis in mice through anti-inflammatory and anti-oxidative pathways. Biochemical and Biophysical Research Communications 2016; 470(1): 22 doi: 10.1016/j.bbrc.2015.12.080
|
10 |
Yongpeng Wang, Lei Tian, Yudan Wang, Tianrui Zhao, Afsar Khan, Yifen Wang, Jianxin Cao, Guiguang Cheng. Protective effect of Que Zui tea hot-water and aqueous ethanol extract against acetaminophen-induced liver injury in miceviainhibition of oxidative stress, inflammation, and apoptosis. Food & Function 2021; 12(6): 2468 doi: 10.1039/D0FO02894K
|
11 |
Xin Zhao, MingJiang Liu, JinGui Li, ShaoJie Yin, YangYang Wu, AnYuan Wang. Antimalarial agent artesunate protects Concanavalin A-induced autoimmune hepatitis in mice by inhibiting inflammatory responses. Chemico-Biological Interactions 2017; 274: 116 doi: 10.1016/j.cbi.2017.07.012
|
12 |
Nevien Hendawy. Pentoxifylline attenuates cytokine stress and Fas system in syngeneic liver proteins induced experimental autoimmune hepatitis. Biomedicine & Pharmacotherapy 2017; 92: 316 doi: 10.1016/j.biopha.2017.05.084
|
13 |
Lei Zhang, Dazhi Chen, Yulu Tu, Tiantian Sang, Tongtong Pan, Hongwei Lin, Chao Cai, Xiaozhi Jin, Faling Wu, Lanman Xu, Yongping Chen. Vitexin attenuates autoimmune hepatitis in mouse induced by syngeneic liver cytosolic proteins via activation of AMPK/AKT/GSK-3β/Nrf2 pathway. European Journal of Pharmacology 2022; 917: 174720 doi: 10.1016/j.ejphar.2021.174720
|
14 |
Albert J. Czaja. Epigenetic changes and their implications in autoimmune hepatitis. European Journal of Clinical Investigation 2018; 48(4) doi: 10.1111/eci.12899
|
15 |
Márcia Maria Medeiros de Ataides Bezerra, Isabela Cristina de Farias Andrade, Júlio Cesar Dias de Melo Silva, Ana Clara Santos Costa, Raldney Ricardo Costa da Silva, Luydson Richardison Silva Vasconcelos, Maria de Fátima Cavalcanti Toscano Barreto, Leila Maria Moreira Beltrão Pereira, Sura Wanessa Santos Rocha. Hepatic expression of tumor necrosis factor-α and evaluation of MAPK-p38 and NFκB signaling pathways in autoimmune hepatitis. Cytokine 2024; 177: 156541 doi: 10.1016/j.cyto.2024.156541
|
16 |
Esraa Moustafa ELnahas, Mahdy Salama Abou Zeid, Hala Salah Abdel Kawy, Nevien Hendawy, Walaa Baher. Celecoxib attenuates depressive-like behavior associated with immunological liver injury in C57BL/6 mice through TNF-α and NF-κb dependent mechanisms. Life Sciences 2016; 163: 23 doi: 10.1016/j.lfs.2016.08.027
|
17 |
Urs Christen. Animal models of autoimmune hepatitis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 970 doi: 10.1016/j.bbadis.2018.05.017
|
18 |
Guo Ai, Weiming Yan, Haijing Yu, Fang Xiao, Dong Xi, Ke Ma, Jiaquan Huang, Xiaoping Luo, Xiaoyang Wan, Qin Ning. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function. The Journal of Gene Medicine 2018; 20(7-8) doi: 10.1002/jgm.3023
|
19 |
Dao-Feng Ben, Xi-Ya Yu, Guang-Yu Ji, De-Yi Zheng, Kai-Yang Lv, Bing Ma, Zhao-Fan Xia. TLR4 Mediates Lung Injury and Inflammation in Intestinal Ischemia-Reperfusion. Journal of Surgical Research 2012; 174(2): 326 doi: 10.1016/j.jss.2010.12.005
|
20 |
Haijing Yu, Jiaquan Huang, Yang Liu, Guo Ai, Weiming Yan, Xiaojing Wang, Qin Ning. IL-17 contributes to autoimmune hepatitis. Journal of Huazhong University of Science and Technology [Medical Sciences] 2010; 30(4): 443 doi: 10.1007/s11596-010-0446-0
|
21 |
Shou-Pei Liu, Zhen-Hua Bian, Zhi-Bin Zhao, Jinjun Wang, Weici Zhang, Patrick S.C. Leung, Liang Li, Zhe-Xiong Lian. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2020; 58(2): 252 doi: 10.1007/s12016-020-08778-6
|
22 |
Ya‐Fei Xu, Zhi‐Bin Zhao, Ethan P. Yan, Zhe‐Xiong Lian, Weici Zhang. Complex interplay between the immune system, metabolism, and epigenetic factors in autoimmune liver diseases. Medicine Advances 2023; 1(2): 97 doi: 10.1002/med4.23
|
23 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmmune hepatitis. Cellular & Molecular Immunology 2022; 19(2): 158 doi: 10.1038/s41423-021-00768-8
|
24 |
Miao Zhang, Qingxia Li, Cuisong Zhou, Yaxing Zhao, Ruiyan Li, Yubin Zhang. Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling. International Immunopharmacology 2020; 80: 106137 doi: 10.1016/j.intimp.2019.106137
|
25 |
Albert J Czaja. Autoimmune liver disease. Current Opinion in Gastroenterology 2008; 24(3): 298 doi: 10.1097/MOG.0b013e3282f57268
|